Beyond glycaemic management – the role of SGLT2i in the T2D treatment algorithm
With a focus on how to individualise diabetes treatment regimens based on patients’ risk profiles and comorbidities, this program covers how to differentiate between the different classes of glucose-lowering medicines as they pertain to specific clinical situations.
Sign up for free and continue reading
Med CPD offers the widest range of courses and content, all accessible in one place. Click on the Sign up button and start looking after the health of your career.
MDBriefCase Group Inc.
Speakers
Dr Anita Sharma
Dr Esther Briganti
Duration
1 H
Accredited
-
RACGP - Royal Australian College of General Practitioners